Picture of Agenus logo

AGEN — Agenus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Agenus Inc expected to post a loss of 5 cents a share - Earnings Preview

* Agenus Inc  AGEN.OQ   AGEN.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 14 for the
period ending December 31 2023
    * The Lexington Massachusetts-based  company is expected to
report
a 65.8% increase in revenue to $47.055 million from $28.39
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Agenus Inc is for a loss
of 5
cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Agenus Inc
is
$6.00​, above​ its last closing price of $0.67. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.19       -0.19      -0.16     Beat    16.7
 Jun. 30 2023  -0.19       -0.20      -0.20     Met     -0.8
 Mar. 31 2023  -0.21       -0.21      -0.22     Missed  -4.8​
 Dec. 31 2022  -0.23       -0.22      -0.24     Missed  -9.9
 ​​Sep.        -0.19       -0.19      -0.19     Met     -1.3
 30 2022                                                
 Jun. 30 2022  -0.23       -0.23      -0.17     Beat    26.1​
 Mar. 31 2022  -0.30       -0.30      -0.19     Beat    36.1
 Dec. 31 2021  -0.17       -0.16      -0.26     Missed  -65.1
 This summary was machine generated March 12 at 12:51 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Agenus

See all news